ULBP2, one of the NKG2D ligands (NKG2DL), has been detected on the surface of tumor cells and identified as a prognostic biomarker in different tumors (Paschen et al., 2009; Nückel et al., 2010). Here, KLRK1 is linked to neoplasm.